Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab.
- Citation:
- Prostate Cancer Prostatic Dis
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- Parents:
- 3474
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233253, UG1CA233341, United States Army Medical Research W81XWH-18-1-0278
- Corr. Author:
- Authors:
- Andrew B Nixon Yingmiao Liu Qian Yang Bin Luo Mark D Starr John C Brady Wm Kevin Kelly Himisha Beltran Michael J Morris Daniel J George Andrew J Armstrong Susan Halabi
- Networks:
- LAPS-MA036, LAPS-NC010, LAPS-NY016
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: